Results 141 to 150 of about 683,284 (269)
Progress and Prospects of Persistent Luminescent Nanocrystals in Biomedical Applications
This review summarizes recent progress in materials‐level control of persistent luminescence, including mechanistic understanding, wavelength/intensity tuning, and activation strategies, as well as emerging biomedical applications in imaging, biosensing, cell tracking, optogenetic stimulation, and biophotochemical activation.
Peng Pei +5 more
wiley +1 more source
Evaluating Differential Metabolic Profiles by Prostate Cancer Risk Among Prostate Cancer Patients. [PDF]
Liu T +8 more
europepmc +1 more source
Prostate biopsy: is age important for determining the pathological features in prostate cancer? [PDF]
Alberto A. Antunes +5 more
openalex +1 more source
This Review focuses on assessing and providing perspective on the field of rationally‐designed optical sensors constructed with single‐walled carbon nanotubes. The literature is reviewed and evaluated for SWCNT‐based sensors constructed with biomolecular recognition elements, including proteins, peptides, and oligonucleotides, as well as their methods ...
Amelia K. Ryan +4 more
wiley +1 more source
Prognostic impact of spatial niches in prostate cancer. [PDF]
Schneider F +10 more
europepmc +1 more source
YAP undergoes phase separation to activate the AJUBA super‐enhancer, driving aberrant mitosis through spindle checkpoint dysregulation in breast cancer. This study uncovers a mechanistic link between YAP condensates, super‐enhancer activation, and aneuploidy formation.
Rui Zhang +8 more
wiley +1 more source
Serum metabolites with diagnostic potential in prostate cancer and the inhibitory effects of alpha-Tocomonoenol on prostate cancer cells. [PDF]
Shen Y +7 more
europepmc +1 more source
ARN-509 in Men with Metastatic Castration-Resistant Prostate Cancer (CRPC)
Dana E. Rathkopf +9 more
openalex +1 more source
This study successfully establishes adamantinomatous craniopharyngioma (ACP) patient‐derived organoids (PDOs) that preserve the histopathological and genetic features of the original tumors. Through drug sensitivity assays and subsequent mechanistic analyses, the study demonstrates that Ceritinib exerts its inhibitory effects on ACP PDO growth by ...
Huarong Zhang +15 more
wiley +1 more source

